Windtree Therapeutics Regains Nasdaq Compliance with Minimum Bid Price Requirement
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a clinical-stage biopharmaceutical company, has successfully navigated back to compliance with Nasdaq’s minimum bid price requirement, a crucial step for maintaining its …
Windtree Therapeutics Regains Nasdaq Compliance with Minimum Bid Price Requirement Read More